Shares in Intercell AG received a significant boost Tuesday on news that the FDA approved its Japanese Encephalitis Virus (JEV) vaccine Ixiaro late Monday. (BioWorld International)

The Merck Serono division of Merck KGaA has launched a new corporate venture capital arm, Merck Serono Ventures, to give the company early visibility on emerging innovation in its parent's core area of focus. (BioWorld International) BioWorld International CorrespondentThe Merck Serono division of Merck KGaA has launched a new corporate venture capital arm, Merck Serono Ventures, to give the company early visibility on emerging innovation in its parent's core area of focus.